FDA Inspection 1012258 — American Red Cross Biomedical Services IRB
The FDA completed an inspection of American Red Cross Biomedical Services IRB on May 24, 2017 in Rockville, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 24, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Rockville, MD (United States)
Additional Details
IRB